lgx818
Showing 1 - 11 of 11
Melanoma and Metastatic Colorectal Cancer Trial in Worldwide (LGX818)
Active, not recruiting
- Melanoma and Metastatic Colorectal Cancer
- LGX818
-
Toulouse, Haute-garonne, France
- +7 more
Dec 2, 2021
Solid Tumors Harboring a BRAF V600 Mutation Trial in Worldwide (LGX818, MEK162, LEE011)
Active, not recruiting
- Solid Tumors Harboring a BRAF V600 Mutation
- LGX818
- +2 more
-
Tampa, Florida
- +22 more
Mar 16, 2022
Solid Tumor, Hematologic Malignancies Trial in United States (LGX818)
Terminated
- Solid Tumor
- Hematologic Malignancies
- LGX818
-
Birmingham, Alabama
- +12 more
Mar 1, 2021
NSCLC Trial in Chicago (LGX818)
Withdrawn
- Non-Small Cell Lung Cancer
- LGX818
-
Chicago, IllinoisUniversity of Chicago Medical Center SC-2
Nov 11, 2020
Metastatic Melanoma Trial in Worldwide (LGX818, MEK162, Nivolumab)
Active, not recruiting
- Metastatic Melanoma
- LGX818
- +3 more
-
Salzburg, AT, Austria
- +29 more
Feb 23, 2022
Colorectal Cancer Trial in Worldwide (LGX818, Cetuximab, BYL719)
Completed
- Colorectal Cancer
- LGX818
- +2 more
-
Los Angeles, California
- +51 more
May 26, 2021
Melanoma Trial in Worldwide (LGX818, MEK162, LEE011)
Active, not recruiting
- Melanoma
- LGX818
- +5 more
-
Los Angeles, California
- +31 more
Jun 11, 2021
Locally Advanced Metastatic BRAF Mutant Melanoma Trial in Worldwide (LEE011, LGX818)
Terminated
- Locally Advanced Metastatic BRAF Mutant Melanoma
- LEE011
- LGX818
-
Aurora, Colorado
- +8 more
Jul 27, 2016